Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Best

Showing results (1221-1230 of 1,265) with videos related to

Pageof 127
Sort By:
Plos Pathogens|January 19, 2021
K18-hACE2 mice develop respiratory disease resembling severe COVID-19Claude Kwe Yinda, Julia R Port, Trenton Bushmaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2020
The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activationJian Wu, Lu Xia, Xiangyu Yao, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
AIDS (London, England)|November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2017
Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patientsM Best, M Jachiet, N Molinari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Molecular alterations in primary prostate cancer after androgen ablation therapyCarolyn J M Best, John W Gillespie, Yajun Yi, et al.
Journal of Medicinal Chemistry|April 28, 2012
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas diseaseMartine Keenan, Michael J Abbott, Paul W Alexander, et al.
Journal of Molecular and Cellular Cardiology|February 26, 2023
Caveolin-3 and Caveolae regulate ventricular repolarizationYogananda S Markandeya, Zachery R Gregorich, Li Feng, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
Pageof 127

Showing results (1221-1230 of 1,265) with videos related to

Sort By:
Pageof 127
Plos Pathogens|January 19, 2021
K18-hACE2 mice develop respiratory disease resembling severe COVID-19Claude Kwe Yinda, Julia R Port, Trenton Bushmaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2020
The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activationJian Wu, Lu Xia, Xiangyu Yao, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s studyMarije Van Schalkwyk, Adrie Bekker, Eric Decloedt, et al.
AIDS (London, England)|November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIVKristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2017
Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patientsM Best, M Jachiet, N Molinari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Molecular alterations in primary prostate cancer after androgen ablation therapyCarolyn J M Best, John W Gillespie, Yajun Yi, et al.
Journal of Medicinal Chemistry|April 28, 2012
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas diseaseMartine Keenan, Michael J Abbott, Paul W Alexander, et al.
Journal of Molecular and Cellular Cardiology|February 26, 2023
Caveolin-3 and Caveolae regulate ventricular repolarizationYogananda S Markandeya, Zachery R Gregorich, Li Feng, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
Pageof 127